Global Human Microbiome Modulators Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
出版日期：2019/07/29
頁 數：122頁
文件格式：PDF
價 格：
USD 3,480 (Single-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
Scope of the Report:
The global Human Microbiome Modulators market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Microbiome Modulators.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Human Microbiome Modulators market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Microbiome Modulators market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
Market Segment by Applications, can be divided into
Digestive Health
Immune Health
Oral Health
Others
Scope of the Report:
The global Human Microbiome Modulators market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Microbiome Modulators.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Human Microbiome Modulators market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Microbiome Modulators market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
Market Segment by Applications, can be divided into
Digestive Health
Immune Health
Oral Health
Others
Table of Contents
1 Human Microbiome Modulators Market Overview
1.1 Product Overview and Scope of Human Microbiome Modulators
1.2 Classification of Human Microbiome Modulators by Types
1.2.1 Global Human Microbiome Modulators Revenue Comparison by Types (2019-2024)
1.2.2 Global Human Microbiome Modulators Revenue Market Share by Types in 2018
1.2.3 Probiotics and Creams
1.2.4 Prebiotics and Dietary Supplements
1.2.5 Drugs
1.3 Global Human Microbiome Modulators Market by Application
1.3.1 Global Human Microbiome Modulators Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Digestive Health
1.3.3 Immune Health
1.3.4 Oral Health
1.3.5 Others
1.4 Global Human Microbiome Modulators Market by Regions
1.4.1 Global Human Microbiome Modulators Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Microbiome Modulators Status and Prospect (2014-2024)
1.5 Global Market Size of Human Microbiome Modulators (2014-2024)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Human Microbiome Modulators Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.2 BioGaia
2.2.1 Business Overview
2.2.2 Human Microbiome Modulators Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioGaia Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.3 Chr. Hansen Holding
2.3.1 Business Overview
2.3.2 Human Microbiome Modulators Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chr. Hansen Holding Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.4 DowDuPont
2.4.1 Business Overview
2.4.2 Human Microbiome Modulators Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 DowDuPont Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.5 Ingredion
2.5.1 Business Overview
2.5.2 Human Microbiome Modulators Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ingredion Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.6 ISOThrive
2.6.1 Business Overview
2.6.2 Human Microbiome Modulators Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ISOThrive Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jarrow Formulas
2.7.1 Business Overview
2.7.2 Human Microbiome Modulators Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jarrow Formulas Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.8 DSM
2.8.1 Business Overview
2.8.2 Human Microbiome Modulators Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DSM Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.9 Lallemand
2.9.1 Business Overview
2.9.2 Human Microbiome Modulators Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lallemand Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Human Microbiome Modulators Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Microbiome Modulators Market Competition, by Players
3.1 Global Human Microbiome Modulators Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Microbiome Modulators Players Market Share
3.2.2 Top 10 Human Microbiome Modulators Players Market Share
3.3 Market Competition Trend
4 Global Human Microbiome Modulators Market Size by Regions
4.1 Global Human Microbiome Modulators Revenue and Market Share by Regions
4.2 North America Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.3 Europe Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.5 South America Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5 North America Human Microbiome Modulators Revenue by Countries
5.1 North America Human Microbiome Modulators Revenue by Countries (2014-2019)
5.2 USA Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5.3 Canada Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5.4 Mexico Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6 Europe Human Microbiome Modulators Revenue by Countries
6.1 Europe Human Microbiome Modulators Revenue by Countries (2014-2019)
6.2 Germany Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.3 UK Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.4 France Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.5 Russia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.6 Italy Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Human Microbiome Modulators Revenue by Countries
7.1 Asia-Pacific Human Microbiome Modulators Revenue by Countries (2014-2019)
7.2 China Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.3 Japan Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.4 Korea Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.5 India Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8 South America Human Microbiome Modulators Revenue by Countries
8.1 South America Human Microbiome Modulators Revenue by Countries (2014-2019)
8.2 Brazil Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8.3 Argentina Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8.4 Colombia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Human Microbiome Modulators by Countries
9.1 Middle East and Africa Human Microbiome Modulators Revenue by Countries (2014-2019)
9.2 Saudi Arabia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.3 UAE Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.4 Egypt Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.5 Nigeria Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.6 South Africa Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
10 Global Human Microbiome Modulators Market Segment by Type
10.1 Global Human Microbiome Modulators Revenue and Market Share by Type (2014-2019)
10.2 Global Human Microbiome Modulators Market Forecast by Type (2019-2024)
10.3 Probiotics and Creams Revenue Growth Rate (2014-2024)
10.4 Prebiotics and Dietary Supplements Revenue Growth Rate (2014-2024)
10.5 Drugs Revenue Growth Rate (2014-2024)
11 Global Human Microbiome Modulators Market Segment by Application
11.1 Global Human Microbiome Modulators Revenue Market Share by Application (2014-2019)
11.2 Human Microbiome Modulators Market Forecast by Application (2019-2024)
11.3 Digestive Health Revenue Growth (2014-2019)
11.4 Immune Health Revenue Growth (2014-2019)
11.5 Oral Health Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Human Microbiome Modulators Market Size Forecast (2019-2024)
12.1 Global Human Microbiome Modulators Market Size Forecast (2019-2024)
12.2 Global Human Microbiome Modulators Market Forecast by Regions (2019-2024)
12.3 North America Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.4 Europe Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.6 South America Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Human Microbiome Modulators Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Human Microbiome Modulators Market Overview
1.1 Product Overview and Scope of Human Microbiome Modulators
1.2 Classification of Human Microbiome Modulators by Types
1.2.1 Global Human Microbiome Modulators Revenue Comparison by Types (2019-2024)
1.2.2 Global Human Microbiome Modulators Revenue Market Share by Types in 2018
1.2.3 Probiotics and Creams
1.2.4 Prebiotics and Dietary Supplements
1.2.5 Drugs
1.3 Global Human Microbiome Modulators Market by Application
1.3.1 Global Human Microbiome Modulators Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Digestive Health
1.3.3 Immune Health
1.3.4 Oral Health
1.3.5 Others
1.4 Global Human Microbiome Modulators Market by Regions
1.4.1 Global Human Microbiome Modulators Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Human Microbiome Modulators Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Microbiome Modulators Status and Prospect (2014-2024)
1.5 Global Market Size of Human Microbiome Modulators (2014-2024)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Human Microbiome Modulators Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.2 BioGaia
2.2.1 Business Overview
2.2.2 Human Microbiome Modulators Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioGaia Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.3 Chr. Hansen Holding
2.3.1 Business Overview
2.3.2 Human Microbiome Modulators Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chr. Hansen Holding Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.4 DowDuPont
2.4.1 Business Overview
2.4.2 Human Microbiome Modulators Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 DowDuPont Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.5 Ingredion
2.5.1 Business Overview
2.5.2 Human Microbiome Modulators Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ingredion Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.6 ISOThrive
2.6.1 Business Overview
2.6.2 Human Microbiome Modulators Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ISOThrive Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jarrow Formulas
2.7.1 Business Overview
2.7.2 Human Microbiome Modulators Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jarrow Formulas Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.8 DSM
2.8.1 Business Overview
2.8.2 Human Microbiome Modulators Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DSM Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.9 Lallemand
2.9.1 Business Overview
2.9.2 Human Microbiome Modulators Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lallemand Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Human Microbiome Modulators Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Microbiome Modulators Market Competition, by Players
3.1 Global Human Microbiome Modulators Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Microbiome Modulators Players Market Share
3.2.2 Top 10 Human Microbiome Modulators Players Market Share
3.3 Market Competition Trend
4 Global Human Microbiome Modulators Market Size by Regions
4.1 Global Human Microbiome Modulators Revenue and Market Share by Regions
4.2 North America Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.3 Europe Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.5 South America Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5 North America Human Microbiome Modulators Revenue by Countries
5.1 North America Human Microbiome Modulators Revenue by Countries (2014-2019)
5.2 USA Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5.3 Canada Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
5.4 Mexico Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6 Europe Human Microbiome Modulators Revenue by Countries
6.1 Europe Human Microbiome Modulators Revenue by Countries (2014-2019)
6.2 Germany Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.3 UK Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.4 France Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.5 Russia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
6.6 Italy Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Human Microbiome Modulators Revenue by Countries
7.1 Asia-Pacific Human Microbiome Modulators Revenue by Countries (2014-2019)
7.2 China Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.3 Japan Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.4 Korea Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.5 India Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8 South America Human Microbiome Modulators Revenue by Countries
8.1 South America Human Microbiome Modulators Revenue by Countries (2014-2019)
8.2 Brazil Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8.3 Argentina Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
8.4 Colombia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Human Microbiome Modulators by Countries
9.1 Middle East and Africa Human Microbiome Modulators Revenue by Countries (2014-2019)
9.2 Saudi Arabia Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.3 UAE Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.4 Egypt Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.5 Nigeria Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
9.6 South Africa Human Microbiome Modulators Revenue and Growth Rate (2014-2019)
10 Global Human Microbiome Modulators Market Segment by Type
10.1 Global Human Microbiome Modulators Revenue and Market Share by Type (2014-2019)
10.2 Global Human Microbiome Modulators Market Forecast by Type (2019-2024)
10.3 Probiotics and Creams Revenue Growth Rate (2014-2024)
10.4 Prebiotics and Dietary Supplements Revenue Growth Rate (2014-2024)
10.5 Drugs Revenue Growth Rate (2014-2024)
11 Global Human Microbiome Modulators Market Segment by Application
11.1 Global Human Microbiome Modulators Revenue Market Share by Application (2014-2019)
11.2 Human Microbiome Modulators Market Forecast by Application (2019-2024)
11.3 Digestive Health Revenue Growth (2014-2019)
11.4 Immune Health Revenue Growth (2014-2019)
11.5 Oral Health Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Human Microbiome Modulators Market Size Forecast (2019-2024)
12.1 Global Human Microbiome Modulators Market Size Forecast (2019-2024)
12.2 Global Human Microbiome Modulators Market Forecast by Regions (2019-2024)
12.3 North America Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.4 Europe Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.6 South America Human Microbiome Modulators Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Human Microbiome Modulators Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
